| | | | | | |
CUSIP NO. | | 83410S108 | | 13D | | PAGE 3 OF 6 PAGES |
Amendment No. 11 to Schedule 13D
This Amendment No. 11 (this “Amendment”) amends the Schedule 13D filed by Dr. Charles Zhang (“Dr. Zhang”) with the Securities and Exchange Commission (the “SEC”) on June 16, 2004, as amended by Amendment No. 1 filed with the SEC on April 1, 2010 (“Amendment No. 1”), by Amendment No. 2 filed with the SEC on July 8, 2011 (“Amendment No. 2”), by Amendment No. 3 filed with the SEC on December 14, 2015 (“Amendment No. 3”), by Amendment No. 4 filed with the SEC on June 20, 2016 (“Amendment No. 4”), by Amendment No. 5 filed with the SEC on May 30, 2017 (“Amendment No. 5”), by Amendment No. 6 filed with the SEC on February 1, 2018 (“Amendment No. 6”), by Amendment No. 7 filed with the SEC on June 8, 2018 (“Amendment No. 7”), by Amendment No. 8 filed with the SEC on September 21, 2018 (“Amendment No. 8”), by Amendment No. 9 filed with the SEC on December 20, 2018 (“Amendment No. 9”), and by Amendment No. 10 filed with the SEC on June 21, 2019 (“Amendment No. 10”). The original Schedule 13D of Dr. Zhang, as amended by Amendment No. 1, Amendment No. 2, Amendment No. 3, Amendment No. 4, Amendment No. 5, Amendment No. 6, Amendment No. 7, Amendment No. 8, Amendment No. 9, and Amendment No. 10 is hereinafter referred to as the “Initial Statement.”
Item 4. | Purpose of the Transaction. |
Item 4 of the Initial Statement is hereby supplemented as follows:
On September 9, 2019, Dr. Zhang delivered a letter to the board of directors (the “Changyou Board”) of Changyou.com Limited (“Changyou”), an indirect majority-owned subsidiary of the Issuer, notifying the Changyou Board that he was withdrawing thenon-binding proposal to acquire all of the outstanding Class A and Class B ordinary shares of Changyou that he had delivered to the Changyou Board on May 22, 2017 and supplemented in a letter delivered to the Changyou Board on January 30, 2018. The letter delivered to the Changyou Board on May 22, 2017 is included as Exhibit 2.1 to aForm 8-K filed with the SEC by Sohu.com Inc., a predecessor of the Issuer, on May 23, 2017, and the letter delivered to the Changyou Board on January 30, 2018 is included as Exhibit 2.1 to aForm 8-K filed with the SEC by Sohu.com Inc. on February 1, 2018.
Item 5. | Interest in Securities of the Issuer. |
Item 5 of the Initial Statement is hereby amended and restated to read in its entirety as follows:
| (a) | Amount Beneficially Owned: |
As of the date of this Amendment, Dr. Zhang beneficially owns or may be deemed to beneficially own 10,056,807 ordinary shares, par value $0.001 per share (“Ordinary Shares”)1, of the Issuer.
1 | Includes (i) 268,700 Ordinary Shares represented by American depositary shares (“ADSs”) held by Dr. Zhang; (ii) 75,000 Ordinary Shares issuable upon the exercise of share options held by Dr. Zhang that are vested or will vest within 60 days following the date of this Amendment; and (iii) 9,713,107 Ordinary Shares represented by ADSs held by Photon Group Limited, a British Virgin Islands corporation (“Photon”). Dr. Zhang is one of the Directors of Photon, and may be deemed to beneficially own such 9,713,107 Ordinary Shares beneficially owned by Photon. Dr. Zhang shares with the other Directors of Photon the power to vote and dispose of or direct the disposition of such 9,713,107 Ordinary Shares. Dr. Zhang disclaims beneficial ownership of such 9,713,107 Ordinary Shares represented by the ADSs held by Photon except to the extent of his pecuniary interest in such Ordinary Shares. Photon is a British Virgin Islands corporation with principal offices at P.O. Box 957, Offshore Incorporations Centre, Road Town, Tortola, British Virgin Islands. Photon is an investment holding company. During the five years prior to the date of this Amendment, neither Photon nor any of its directors, officers, shareholders, or control persons has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). Also, during the five years prior to the date hereof, neither Photon nor any of its directors, officers, shareholders, or control persons has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction which resulted in a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. |